Orient Europharma Co Ltd Cash Flow Quality Index
Orient Europharma Co Ltd cash flow quality index. Orient Europharma Co Ltd (4120) has a Cash Flow Quality Index of 6.11x as of September 2024. Operating cash flow of NT$69.52 Million exceeds net income of NT$11.38 Million, indicating high earnings quality where cash backs reported profits. See Orient Europharma Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Orient Europharma Co Ltd (2015–2023)
Cash flow quality index of Orient Europharma Co Ltd from 2015 to 2023. Historical Cash Flow Quality Index for Orient Europharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Orient Europharma Co Ltd to assess how comfortably operating cash covers total debt obligations.
Orient Europharma Co Ltd Cash Flow Quality Index by Year (2015–2023)
Orient Europharma Co Ltd cash flow quality index by year from 2015 to 2023. Year-by-year earnings quality comparison for Orient Europharma Co Ltd. For the full cash flow conversion analysis, see 4120 cash flow conversion.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.45x | NT$64.67 Million | NT$143.94 Million | ▼ -30.5% |
| 2021 | 0.65x | NT$77.65 Million | NT$120.17 Million | ▼ -78.8% |
| 2020 | 3.05x | NT$608.55 Million | NT$199.30 Million | ▲ +232.6% |
| 2019 | 0.92x | NT$227.37 Million | NT$247.66 Million | ▼ -2.1% |
| 2018 | 0.94x | NT$231.31 Million | NT$246.74 Million | ▼ -28.5% |
| 2017 | 1.31x | NT$601.08 Million | NT$458.73 Million | ▲ +453.2% |
| 2016 | 0.24x | NT$111.24 Million | NT$469.61 Million | ▼ -91.8% |
| 2015 | 2.89x | NT$643.97 Million | NT$223.16 Million | — |